You are about to read the most exciting grouping of sentences that an OmniPod user could ever wish to hear.
This is the entire announcement from Insult. If you want the legalese and investor info, you can read it here.
New Insulet PDM Will Receive Dexcom G5 CGM Sensor Signals
BEDFORD, MA -- (Marketwired) -- 08/05/14 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, and DexCom, Inc (NASDAQ: DXCM), the leader in continuous glucose monitoring ("CGM") technology, today announced their intention to allow information from Dexcom's 5th generation CGM system to be identified, received and displayed on Insulet's new Bluetooth-enabled Personal Diabetes Manager ("PDM"), currently in development.
This project expands upon the initial agreement announced in June to enable the Dexcom mobile app platform to integrate data from Insulet's OmniPod System. That platform will be the first of its kind to enable glucose and pump data to be displayed on a smartphone.
"We are pleased to expand our development relationship with Dexcom to receive and display Dexcom G5 Sensor data on our new PDM, eliminating the need to carry a separate CGM receiver," said Duane DeSisto, President and Chief Executive Officer of Insulet. "This collaboration furthers our shared vision of helping people living with diabetes by providing greater access to the data they need to make smart and effective decisions to better manage and control their disease."
"We are pleased to be back working with Insulet to bring our leading-edge technologies together to help people living with diabetes better manage their disease," said Kevin Sayer, President and Chief Operating Officer of Dexcom.